153 related articles for article (PubMed ID: 2603883)
1. Pharmacists' evaluations of the nonprescription availability of metaproterenol, cimetidine, ibuprofen, and nystatin.
Madhavan S; Schondelmeyer SW
Am J Hosp Pharm; 1989 Dec; 46(12):2486-92. PubMed ID: 2603883
[TBL] [Abstract][Full Text] [Related]
2. Pharmacists' readiness to assess consumers' over-the-counter product selections.
Taylor J; Berger B; Anderson-Harper H; Grimley D
J Am Pharm Assoc (Wash); 2000; 40(4):487-94. PubMed ID: 10932457
[TBL] [Abstract][Full Text] [Related]
3. Applying the theory of planned behaviour to pharmacists' beliefs and intentions about the treatment of vaginal candidiasis with non-prescription medicines.
Walker A; Watson M; Grimshaw J; Bond C
Fam Pract; 2004 Dec; 21(6):670-6. PubMed ID: 15520031
[TBL] [Abstract][Full Text] [Related]
4. Ibuprofen: a model medicine for self-care of common conditions.
Maguire TA
Int J Clin Pract Suppl; 2013 Jan; (178):43-6. PubMed ID: 23163548
[TBL] [Abstract][Full Text] [Related]
5. Ethical ideology and product confidence: future pharmacists' attitudes toward generic drug substitution.
Pelton LE; Smith MC
Health Mark Q; 1991; 8(3-4):181-92. PubMed ID: 10111968
[TBL] [Abstract][Full Text] [Related]
6. Migraine therapy: a survey of pharmacists' knowledge, attitudes, and practice patterns.
Wenzel RG; Lipton RB; Diamond ML; Cady R
Headache; 2005 Jan; 45(1):47-52. PubMed ID: 15663613
[TBL] [Abstract][Full Text] [Related]
7. Emergency contraceptive pills: dispensing practices, knowledge and attitudes of South Dakota pharmacists.
Hellerstedt WL; Van Riper KK
Perspect Sex Reprod Health; 2005 Mar; 37(1):19-24. PubMed ID: 15888399
[TBL] [Abstract][Full Text] [Related]
8. Market exclusivity after a prescription to nonprescription drug switch: striking the right balance between innovation and competition.
Kraushaar KJ
Food Drug Law J; 1999; 54(2):243-4. PubMed ID: 11758581
[No Abstract] [Full Text] [Related]
9. [Management of acute infantile diarrhoea: a study on community pharmacy counseling in the Midi-Pyrenees region].
Lapeyre-Mestre M; Pin M
Arch Pediatr; 2004 Aug; 11(8):898-902. PubMed ID: 15288078
[TBL] [Abstract][Full Text] [Related]
10. Effect of patient information on the quality of pharmacists' drug use review decisions.
Warholak-Juarez T; Rupp MT; Salazar TA; Foster S
J Am Pharm Assoc (Wash); 2000; 40(4):500-8. PubMed ID: 10932459
[TBL] [Abstract][Full Text] [Related]
11. PPIs: community pharmacists' perceptions.
Kaczmarek ER; Stewart JE; Hutchinson RA
Contemp Pharm Pract; 1982; 5(3):143-9. PubMed ID: 10256917
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing pharmacists' preference for the legal classification of Rx-to-OTC switched drug products.
Madhaven S
J Clin Pharm Ther; 1993 Aug; 18(4):281-90. PubMed ID: 8227236
[TBL] [Abstract][Full Text] [Related]
13. Pharmacists' views of patient counseling.
Schommer JC; Wiederholt JB
Am Pharm; 1994 Jul; NS34(7):46-53. PubMed ID: 8085538
[TBL] [Abstract][Full Text] [Related]
14. Nonprescription medication purchases and the role of pharmacists as healthcare workers in self-medication in Istanbul.
Gül H; Omurtag G; Clark PM; Tozan A; Ozel S
Med Sci Monit; 2007 Jul; 13(7):PH9-14. PubMed ID: 17599034
[TBL] [Abstract][Full Text] [Related]
15. Over-the-counter prescribing and pharmacists' adoption of new medicines: diffusion of innovations.
Paudyal V; Hansford D; Cunningham S; Stewart D
Res Social Adm Pharm; 2013; 9(3):251-62. PubMed ID: 22835710
[TBL] [Abstract][Full Text] [Related]
16. Telephone survey of Alaskan pharmacists' nonprescription needle-selling practices.
Harbke CR; Fisher DG; Cagle HH; Trubatch BN; Fenaughty AM; Johnson ME
J Urban Health; 2000 Mar; 77(1):113-20. PubMed ID: 10741847
[TBL] [Abstract][Full Text] [Related]
17. Identification and evaluation of pharmacists' commonly used drug information sources.
Wong PS; Ko Y; Sklar GE
Ann Pharmacother; 2009 Feb; 43(2):347-52. PubMed ID: 19193588
[TBL] [Abstract][Full Text] [Related]
18. Do pharmacists' opinions affect their decision to dispense or recommend a visit to a doctor?
Caamaño-Isorna F; Montes A; Takkouche B; Gestal-Otero JJ
Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):659-64. PubMed ID: 15830396
[TBL] [Abstract][Full Text] [Related]
19. Institutional pharmacists' guide to complying with PPI regulations.
Greenberg RB
Am J Hosp Pharm; 1980 Dec; 37(12):1656-9. PubMed ID: 7446540
[TBL] [Abstract][Full Text] [Related]
20. The implementation of a harm minimisation model for the identification and treatment of over-the-counter drug misuse and abuse in community pharmacies in Northern Ireland.
Wazaify M; Hughes CM; McElnay JC
Patient Educ Couns; 2006 Dec; 64(1-3):136-41. PubMed ID: 16431072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
